This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Institute of Radiation Medicine, China Academy of Military Medical Sciences Pla. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Haiyan Yan in Tyrosine Kinase Inhibition
Introduction
Haiyan Yan is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of substances that exhibit tyrosine kinase inhibitory activity. His work has implications for cancer treatment, showcasing the potential to inhibit various tumor cells.
Latest Patents
Haiyan Yan holds 1 patent related to his research. The patent is titled "Substance having tyrosine kinase inhibitory activity and preparation method and use thereof." This patent discloses substances that possess tyrosine kinase inhibitory activity, along with their preparation methods and applications. The compounds described in the patent have shown promising results in inhibiting tumor cells, particularly in the context of liver cancer, lung cancer, and neuroblastoma.
Career Highlights
Throughout his career, Haiyan Yan has worked at prestigious institutions, including the Institute of Radiation Medicine, China Academy of Military Medical Sciences, and the Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China. His research has focused on developing innovative therapeutic strategies for cancer treatment.
Collaborations
Haiyan Yan has collaborated with notable colleagues in his field, including Xiaoming Yang and Lin Wang. These collaborations have contributed to the advancement of research in tyrosine kinase inhibition and its applications in oncology.
Conclusion
Haiyan Yan's contributions to the field of medicinal chemistry, particularly through his patent on tyrosine kinase inhibitors, highlight his role as an innovator in cancer research. His work has the potential to lead to new therapeutic options for patients suffering from various types of cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile